Skip to main content
Caplight Logo









Oniria Therapeutics

Oniria Therapeutics

Private
BarcelonaHealthcare & Life Scienceshttps://www.oniriatherapeutics.com/

Last Round

Grant

Dec 16, 2025

Total Funding Raised

$5.69M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Oniria Therapeutics is a biotechnology company that develops precision oncology therapies designed to counteract cancer resistance and combat disease relapse.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

TET2 activatorprecision oncologycancer treatment resistancesmall molecule drugepigenetic therapyfirst-in-class therapyallosteric activationdormant tumor cellspreclinical biotechcancer relapse preventioncancer biomarkersolid tumorshematologic tumors

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oniria Therapeutics Comparables

Compare Oniria Therapeutics with similar companies based on industry and business-model similarity.

Oniria Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hemispherian AS
83%
HiberCell
75%
Otsuka Holdings
61%

Oniria Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 16, 2025
GrantMay 8, 2025
SeedMay 11, 2023

Key People

Founding team and executive leadership

Esther Riambau

CEO, Co-Founder & Board Member

Founding Team

Oniria Therapeutics Investors

Notable investors and investment history

Oniria Therapeutics investors
InvestorRounds
European UnionGrant
BStartup Banco SabadellSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 63% MoM.

  • Dec 16, 2025

    $2M raised from the European Union.

Oniria Therapeutics Filings

Explore SEC and related filing metadata, where available.

Oniria Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oniria Therapeutics's valuation, stock price, and market status.

Is Oniria Therapeutics a public or private company?

Oniria Therapeutics is a private company.

What is the current stock price of Oniria Therapeutics?

Oniria Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Oniria Therapeutics worth (valuation)?

Valuation information for Oniria Therapeutics is not publicly available.

Can I buy Oniria Therapeutics stock?

Oniria Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Oniria Therapeutics's last funding round?

Funding round information for Oniria Therapeutics is not publicly available.

Who are the main investors in Oniria Therapeutics?

Investor information for Oniria Therapeutics is not publicly disclosed.

Will Oniria Therapeutics IPO soon?

No public IPO plans have been announced for Oniria Therapeutics.

How can I track Oniria Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oniria Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBarcelona
Employee Range17
Year Founded2021
Last FundingDec 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?